authors Cairns, J Armstrong, P Belenkie, I Hirsh, Jack Johnstone, D Knudtson, M Lemieux, M Massel, D Naylor, D Roy, L
has subject area 1102 Cardiorespiratory Medicine and Haematology (FoR) Canada (MeSH) Cardiovascular System & Hematology (Science Metrix) Coronary Disease (MeSH) Cost-Benefit Analysis (MeSH) Fibrinolytic Agents (MeSH) Heparin (MeSH) Humans (MeSH) Thrombolytic Therapy (MeSH)
keywords Canada Coronary Disease Cost-Benefit Analysis Fibrinolytic Agents Heparin Humans Thrombolytic Therapy